gallium has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, RA; Blair, JA; Hodgkins, PS; Winsper, SJ | 1 |
| Ganrot, PO | 1 |
1 review(s) available for gallium and Parkinson Disease
| Article | Year |
|---|---|
Metabolism and possible health effects of aluminum.
Topics: Actin Cytoskeleton; Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Aneuploidy; Animals; Autoimmune Diseases; Beryllium; Biological Transport; Bone and Bones; Brain; Cations; Cell Division; Cells; Chromium; Connective Tissue; Cytoplasm; DNA; Down Syndrome; Encephalitis; Erythrocytes; Feces; Gallium; Humans; Hypersensitivity; Immunity, Cellular; Indium; Intestinal Absorption; Intestinal Mucosa; Lung; Membrane Lipids; Microtubules; Muscular Dystrophies; Nondisjunction, Genetic; Osteomalacia; Parkinson Disease; Renal Dialysis; Scandium; Tissue Distribution; Transferrin; Yttrium; Zirconium | 1986 |
1 other study(ies) available for gallium and Parkinson Disease
| Article | Year |
|---|---|
Gallium-transferrin binding in treated and untreated Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Drug Therapy, Combination; Gallium; Humans; Levodopa; Middle Aged; Parkinson Disease; Protein Binding; Selegiline; Transferrin | 1997 |